Moreover, DDK-3 improves chronic HF conditions by suppressing c-Jun N-terminal kinase (JNK) signaling pathways by inhibiting p38 mitogen-activated protein kinase (p38) (204). This evidence concerns the gene MAPK8 and hydrops fetalis.